Literature DB >> 2013840

Optimal tumor targeting by antibodies: development of a mathematical model.

M J Chappell1, G D Thomas, K R Godfrey, A R Bradwell.   

Abstract

A mathematical model has been developed to optimize tumor targeting with labeled antibodies. The model is compartmental and nonlinear, incorporating saturable binding. Published parameter values have been used in the model, and the resulting stiff differential equations have been solved using FACSIMILE, a computer package that can simulate very stiff differential systems. Results show that successful tumor targeting depends on an optimal combination of antibody dose, affinity, and molecular size. The model has allowed an assessment to be made of the complicated and interrelated dynamic relationships that these factors have on tumor targeting. It has also offered an explanation for previously unsatisfactory results from tumor targeting with labeled antibodies. The structural identifiability of the model parameters is also analyzed and it is shown that, with the prior knowledge of some parameters which is likely in practice, the remaining model parameters are uniquely identifiable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013840     DOI: 10.1007/bf01073870

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  28 in total

1.  Global identifiability of the parameters of nonlinear systems with specified inputs: a comparison of methods.

Authors:  M J Chappell; K R Godfrey; S Vajda
Journal:  Math Biosci       Date:  1990-11       Impact factor: 2.144

2.  Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.

Authors:  R M Sharkey; F J Primus; D Shochat; D M Goldenberg
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

3.  Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction.

Authors:  B R Zeeberg; H N Wagner
Journal:  Bull Math Biol       Date:  1987       Impact factor: 1.758

4.  Effect of dose, molecular size, affinity, and protein binding on tumor uptake of antibody or ligand: a biomathematical model.

Authors:  G D Thomas; M J Chappell; P W Dykes; D B Ramsden; K R Godfrey; J R Ellis; A R Bradwell
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

5.  The computerized derivation of rate equations for enzyme reactions on the basis of the pseudo-steady-state assumption and the rapid-equilibrium assumption.

Authors:  H Ishikawa; T Maeda; H Hikita; K Miyatake
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

6.  Computer simulation of thyroid hormone binding, distribution, and disposal dynamics in man.

Authors:  J J DiStefano; R F Chang
Journal:  Am J Physiol       Date:  1971-11

Review 7.  Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors.

Authors:  A J McEwan; B Shapiro; J C Sisson; W H Beierwaltes; D M Ackery
Journal:  Semin Nucl Med       Date:  1985-04       Impact factor: 4.446

8.  Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

Authors:  S M Larson; J A Carrasquillo; K A Krohn; J P Brown; R W McGuffin; J M Ferens; M M Graham; L D Hill; P L Beaumier; K E Hellström
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans.

Authors:  R R Eger; D G Covell; J A Carrasquillo; P G Abrams; K A Foon; J C Reynolds; R W Schroff; A C Morgan; S M Larson; J N Weinstein
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

Review 10.  Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection.

Authors:  L T Baxter; R K Jain
Journal:  Microvasc Res       Date:  1989-01       Impact factor: 3.514

View more
  2 in total

1.  Influence of barrier-crossing limitations on the amount of macromolecular drug taken up by its target.

Authors:  A Aubrée-Lecat; M C Duban; S Demignot; M Domurado; P Fournié; D Domurado
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

Review 2.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.